↑ 薬物リストへ　← 戻る

Medi-570 0.03 mg    (DrugBank: -)

1 disease
告示番号疾患名（ページ内リンク）臨床試験数
49全身性エリテマトーデス1

49. 全身性エリテマトーデス　［臨床試験数：827，薬物数：638（DrugBank：168），標的遺伝子数：108，標的パスウェイ数：191］
Searched query = "Systemic lupus erythematosus", "SLE"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 827 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT01127321
(ClinicalTrials.gov)		May 201014/4/2010A Safety and Tolerability Study of MEDI-570 in Systemic Lupus ErythematosusA Phase 1, Double-blind, Randomized, Single Ascending Dose Study of the Safety and Tolerability of MEDI-570 in SLELupus Erythematosus, SystemicOther: Placebo;Biological: MEDI-570 0.03 MG;Biological: MEDI-570 0.1 MG;Biological: MEDI-570 0.3 MG;Biological: MEDI-570 1 MGMedImmune LLCAstraZenecaTerminated18 YearsN/AAll44Phase 1United States;Canada;Mexico;Peru;South Africa